mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0003 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0004 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0005 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0007 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0008 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.001 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.001 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |